EVERSPIN TECHNOLOGIES INC. (MRAM) SEC Filings & Earnings Calls
EquiReason read 11 EVERSPIN TECHNOLOGIES INC. SEC filings in the last 12 months. Latest: 8-K on 2026-08-12 — Appointment of Vikas Choudhary as director, effective August 9, 2026, with standard compensation and no disagreement disclosed..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 306.6M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
5 Aug 20268-K · 2.02Record quarterly revenue of $18.7M, above expectations; strong product and non-product revenue growth; guidance raised for Q3 2026.earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q2-2026 | $19M | +42% y/y |
| MRAM product sales · MRAM product · Q2-2026 | $15M | +38% y/y |
| Licensing, royalty, engineering services and other revenue · Non-product · Q2-2026 | $3M | +62% y/y |
| Gross margin · Q2-2026 | 53.9% | |
| GAAP net loss · Q2-2026 | $-4M | |
| Non-GAAP net income · Q2-2026 | $3M | +314% y/y |
| Cash and cash equivalents · Q2-2026 | $44M |
Guidance
Q3 2026 revenue guidance $19.5M-$20.5M vs Q2 actual $18.7M
Q3 revenue guidance midpoint $20M above Q2 actual $18.7M, indicating sequential growth; non-GAAP EPS guidance $0.10-$0.15 vs Q2 $0.11.
Risks flagged
GAAP net loss widened to $3.6M from $0.7M YoY due to higher operating expenses ($14.5M vs $8.7M).
“GAAP operating expenses of $14.5 million, compared to $8.7 million in the second quarter of 2025.” · word for word
5 Aug 202610-QEverspin reported strong Q2 2026 results with revenue up 41.9% YoY and gross margin expansion, though net loss widened due to litigation costs.earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q2-2026 | $19M | +42% y/y |
| Product sales · Q2-2026 | $15M | +38% y/y |
| Gross margin · Q2-2026 | 53.9% | |
| Net loss · Q2-2026 | $-4M | |
| Adjusted net income · Q2-2026 | $3M |
Risks flagged
Litigation risk
“General and administrative expenses increased by $4.2 million, or 114.9%, from $3.6 million during the three months ended June 30, 2025, to $7.8 million during the three months ended June 30, 2026. The increase is primarily due to the litigation costs related to the patent infringement lawsuit” · word for word
Dependence on a small number of transactions for licensing revenue
“Licensing, royalty, engineering services and other revenue is a highly variable revenue item characterized by a small number of transactions annually with revenue based on size and terms of each transaction.” · word for word
29 Apr 20268-K · 2.02Everspin Technologies reported Q1 2026 revenue of $14.9M (up 13% YoY), gross margin 52.7% (up 130bps), GAAP net loss narrowed to $0.3M from $1.2M, non-GAAP net income $2.6M. New $40M defense contract. Q2 guidance: revenue $15.5-16.5M.earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q1-2026 | $15M | +14% y/y |
| MRAM product sales · Q1-2026 | $14M | +28% y/y |
| Licensing, royalty, patent, and other revenue · Q1-2026 | $800000.00 | -62% y/y |
| Gross margin · Q1-2026 | 52.7% | |
| Non-GAAP net income · Q1-2026 | $3M | +550% y/y |
| Cash and cash equivalents · Q1-2026 | $41M | |
| GAAP net loss per diluted share · Q1-2026 | $-0.01 | -80% y/y |
| Non-GAAP net income per diluted share · Q1-2026 | $0.11 | +450% y/y |
Guidance
Q2 2026 revenue guidance $15.5-16.5M; GAAP net loss per share ($0.12)-($0.07); non-GAAP EPS $0.00-$0.03
Q2 revenue guidance midpoint $16.0M implies sequential growth of ~7.6% from Q1 actual $14.9M; non-GAAP EPS guidance near breakeven to slight profit.
Risks flagged
Licensing revenue declined significantly, indicating potential lumpiness in non-product revenue.
“Licensing, royalty, patent, and other revenue $0.8M vs $2.1M, down 62%.”
Operating expenses increased 22% YoY, outpacing revenue growth.
“GAAP operating expenses $10.6M vs $8.7M.”
29 Apr 202610-QEverspin reported Q1 2026 results with product sales up 27.9% YoY, gross margin expansion to 52.7%, and a significantly reduced net loss, though licensing revenue declined sharply.earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q1-2026 | $15M | +13% y/y |
| Product sales · Q1-2026 | $14M | +28% y/y |
| Gross margin · Q1-2026 | 52.7% | |
| Net loss · Q1-2026 | $-296000.00 | |
| Adjusted net income · Q1-2026 | $3M |
Risks flagged
Litigation cost pressure
“General and administrative expenses increased by $1.2 million, or 31.9%, from $3.8 million during the three months ended March 31, 2025, to $5.1 million during the three months ended March 31, 2026. The increase is primarily due to the litigation costs related to the patent infringement lawsuit described in Note 5 to our condensed financial statements includ” · word for word
Licensing revenue volatility
“Licensing, royalty, patent, engineering services and other revenue is a highly variable revenue item characterized by a small number of transactions annually with revenue based on size and terms of each transaction.” · word for word
7 Apr 2026DEF 14AEverspin filed its definitive proxy statement for the 2026 annual meeting, including proposals to elect directors, ratify auditors, approve executive compensation, and increase equity plan shares by 1,800,000.open
Figures in the filing · each found in the filing text
| Total shares outstanding · 2026-03-24 | 23,294,478 | |
| CEO total compensation · FY2025 | $3M | |
| CEO target bonus percentage · FY2025 | 100.0% | |
| Net income · FY2025 | $-586000.00 |
Risks flagged
Equity dilution risk
“Proposal 4 seeks to increase the aggregate number of shares of common stock authorized for issuance under the plan by 1,800,000 shares.”
Litigation cost risk
“General and administrative expenses increased by $1.2 million, or 31.9%, from $3.8 million during the three months ended March 31, 2025, to $5.1 million during the three months ended March 31, 2026. The increase is primarily due to the litigation costs related to the patent infringement lawsuit”
4 Mar 20268-K · 2.02Everspin reported Q4 2025 revenue of $14.8M (+12.1% YoY), MRAM product sales $13.5M (+22.7% YoY), gross margin 50.8% (vs 51.3% prior year), GAAP net income $1.2M ($0.05/diluted share). Full year revenue $55.2M (+9.5% YoY). Q1 2026 guidance:earningsopen
Figures in the filing · each found in the filing text
| Total Revenue · Q4-2025 | $15M | +12% y/y |
| MRAM Product Sales · Q4-2025 | $14M | +23% y/y |
| Licensing, Royalty, Patent, and Other Revenue · Q4-2025 | $1M | -41% y/y |
| Gross Margin · Q4-2025 | 50.8% | |
| GAAP Net Income · Q4-2025 | $1M | 0% y/y |
| Non-GAAP Net Income · Q4-2025 | $3M | -7% y/y |
| Total Revenue (Full Year) · FY2025 | $55M | +10% y/y |
| MRAM Product Sales (Full Year) · FY2025 | $48M | +14% y/y |
| Gross Margin (Full Year) · FY2025 | 51.2% | |
| GAAP Net Loss (Full Year) · FY2025 | $-600000.00 | -175% y/y |
Guidance
Q1 2026 revenue $14.0M-$15.0M; GAAP net loss per share ($0.03)-$0.02; Non-GAAP net income per share $0.07-$0.12.
Q1 2026 guidance implies modest sequential revenue decline from Q4 2025 ($14.8M) but within a reasonable range; management tone positive on design wins and long-term growth.
Risks flagged
Licensing revenue declined significantly in Q4 2025 ($1.3M vs $2.2M) and full year ($6.9M vs $8.2M), indicating potential volatility in non-product revenue streams.
“Licensing, royalty, patent, and other revenue of $1.3 million, compared to $2.2 million in the fourth quarter of 2024.” · word for word
GAAP net loss for full year 2025 ($0.6M) vs net income in 2024 ($0.8M), though non-GAAP remains profitable.
“GAAP net loss of $0.6 million, or $(0.03) per diluted share, compared to net income of $0.8 million” · word for word
4 Mar 202610-KAnnual report with risk factor disclosures including export control self-disclosure and tariff concerns.open
Risks flagged
Export control violation risk
“In October 2024, we submitted to the U.S. Department of Commerce's Bureau of Industry and Security (BIS) an initial notification of voluntary self-disclosure concerning apparent violations.” · word for word
Tariff and trade policy risk
“Current or future tariffs or other restrictive trade measures may significantly raise the costs of raw materials, components or finished goods.” · word for word
Cyclical demand risk
“Further, the semiconductor memory industry is highly cyclical, and our markets may experience significant cyclical fluctuations in demand.” · word for word
5 Nov 202510-QEverspin reports Q3 2025 revenue growth of 16.3% YoY and gross margin expansion, though net income declined.earningsopen
Figures in the filing · each found in the filing text
| Net income · Q3-2025 | $54000.00 | -98% y/y |
| Operating cash flow · 9M-2025 | $7M | +125% y/y |
| Free cash flow · 9M-2025 | $3M |
Risks flagged
Licensing revenue volatility
“Licensing, royalty, patent, and other revenue is a highly variable revenue item characterized by a small number of transactions annually with revenue based on size and terms of each transaction.” · word for word
5 Nov 20258-K · 2.02Everspin reports Q3 2025 revenue $14.1M (+16.5% YoY), gross margin 51.3% (+210bps), GAAP net income $54K vs $2.3M YoY; guides Q4 revenue $14-15M, EPS $0.02-0.07 GAAP.earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q3-2025 | $14M | +17% y/y |
| MRAM product sales · Q3-2025 | $13M | +22% y/y |
| Licensing, royalty, patent, and other revenue · Q3-2025 | $1M | -18% y/y |
| Gross margin · Q3-2025 | 51.3% | |
| GAAP net income · Q3-2025 | $54000.00 | -98% y/y |
| Non-GAAP net income · Q3-2025 | $2M | -61% y/y |
| Cash and cash equivalents · Q3-2025 | $45M |
Guidance
Q4 2025 revenue $14.0-15.0M; GAAP EPS $0.02-0.07; Non-GAAP EPS $0.08-0.13
Q4 guidance implies revenue growth vs Q3 midpoint, with modest EPS improvement.
Risks flagged
Net income decline despite revenue growth signals potential margin pressure from operating expenses or lower other income.
“GAAP net income of $54,000, compared to $2.3 million in Q3 2024.”
Dependence on satellite, gaming, and energy markets may concentrate risk.
“Strength in Low Earth Orbital Satellite, Casino Gaming and Energy Management applications.”
EVERSPIN TECHNOLOGIES INC. — questions
- What did EVERSPIN TECHNOLOGIES INC. file recently?
- 11 SEC filings in the last 12 months. Latest: 8-K on 2026-08-12 — Appointment of Vikas Choudhary as director, effective August 9, 2026, with standard compensation and no disagreement disclosed.
Every figure on this page comes from EVERSPIN TECHNOLOGIES INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.